Citation only
via OpenAlex
Senolytic Drugs, Dasatinib and Quercetin, Attenuate Adipose Tissue T Lymphocyte Infiltration and Improve Metabolic Function in Old Mice
Md Torikul Islam, Eric C. Tuday, John Kim, Tavia Dutson, Tam T. T. Phuong, Anthony J. Donato, Lisa A. Lesniewski
The FASEB Journal · 2021 · ▲ 3 citations
Abstract
Age‐related metabolic dysfunction is accompanied by accumulation of senescent cells and the senescence(definition)‐associated secretory phenotype (SASP) leading to chronic sterile inflammation. Recent evidence suggests that using a genetic approach to clear senescent cells improves metabolic function in old mice. However, the underlying mechanisms and if/how these findings can be translated into clinical practice are largely unknown. Here, we evaluated the impact of treatment with the FDA‐approved drugs, dasatinib and quercetin (D&Q), on tissue senescence burden, T lymphocyte infiltration and systemic metabolic function in 22‐24 month old C57Bl/6 mice. Administration of D&Q resulted in ~50% reduction in expression of the senescence marker p16 in perigonadal white adipose tissue (pgWAT) (p=0.004) and liver (p=0.003) (Fig 1A), but not skeletal muscle (p=0.76). D&Q treatment also resulted in 1 to 4‐fold reduction in expression of pro‐inflammatory SASP genes (i.e., mcp1, cxcl2, il‐6 and il‐1β ) in pgWAT (all p≤0.04; Fig 1B), but not in liver and skeletal muscle (all p≥0.19), suggesting an adipose specific effect of D&Q. Using flow cytometry, we found that the reduced expression of p16 and SASP genes was associated with 30‐50% lower infiltration of total (CD3+), cytotoxic (CD8+) and helper (CD4+) T cells in pgWAT (all p≤0.04; Fig 1C). Treatment with D&Q ameliorated glucose tolerance (2 g/kg, ip) as demonstrated by a lower time response curve (group: p=0.007, interaction: p=0.03, Fig 1D) and reduced area under the curve (p=0.01, Fig 1E). To explore the underlying mechanisms, we assessed glucose‐stimulated (2 g/kg, ip) insulin secretion and insulin tolerance (1 U/kg, ip) and found no differences between groups (both p≥0.19). To assess the impact of D&Q on metabolic function in the liver, we performed a pyruvate tolerance (2 g/kg, ip) test and found that this treatment resulted in improved pyruvate tolerance (group: p=0.08, interaction: p=0.04, Fig 2A) and thus attenuated hepatic gluconeogenesis. Biochemical analysis revealed that phosphorylation of a gluconeogenic transcription factor, cAMP response element binding protein, and transcript level expression of gluconeogenic genes ( pck1, pck2, fbp2 and g6pc ) were lower in D&Q treated mice compared to vehicle treated mice (all p≤0.04; Fig 2B‐D), further supporting our findings of diminished hepatic gluconeogenesis. D&Q treatment also reduced plasma triglycerides (113 ± 5 vs 94 ± 5 mg/dL, p=0.02) and improved adipose tissue sensitivity to insulin as indicated by lower insulin‐stimulated ((1 U/kg, ip) plasma non‐esterified free fatty acids (fasted: 0.63 ± 0.02 vs 0.62 ± 0.06 mmol/L, p=0.87; 15 min: 0.54 ± 0.05 vs 0.33 ± 0.02 mmol/L, p=0.006). Taken together, these results suggest that D&Q improve glucose tolerance and lipid metabolism, associated with an attenuation of adipose inflammation (i.e., reduced SASP gene expression and T cell infiltration) and reduced hepatic gluconeogenesis in old mice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1096/fasebj.2021.35.s1.01969
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Islam, M.T., Tuday, E.C., Kim, J., Dutson, T., Phuong, T.T.T., Donato, A.J., & Lesniewski, L.A. (2021). Senolytic Drugs, Dasatinib and Quercetin, Attenuate Adipose Tissue T Lymphocyte Infiltration and Improve Metabolic Function in Old Mice. <em>The FASEB Journal</em>. https://doi.org/10.1096/fasebj.2021.35.s1.01969
Vancouver
Islam MT, Tuday EC, Kim J, Dutson T, Phuong TTT, Donato AJ, et al. Senolytic Drugs, Dasatinib and Quercetin, Attenuate Adipose Tissue T Lymphocyte Infiltration and Improve Metabolic Function in Old Mice. The FASEB Journal. 2021. doi:10.1096/fasebj.2021.35.s1.01969.
BibTeX
@article{md2021Senoly,
title = {Senolytic Drugs, Dasatinib and Quercetin, Attenuate Adipose Tissue T Lymphocyte Infiltration and Improve Metabolic Function in Old Mice},
author = {Md Torikul Islam and Eric C. Tuday and John Kim and Tavia Dutson and Tam T. T. Phuong and Anthony J. Donato and Lisa A. Lesniewski},
journal = {The FASEB Journal},
year = {2021},
doi = {10.1096/fasebj.2021.35.s1.01969},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2023
Open access · CC-BY
Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age
Physiology 2025
Citation only
Beneficial effects of the senolytic cocktail, dasatinib and quercetin, on age-related vascular and metabolic dysfunction are lost in mice lacking T and B cells
Arteriosclerosis Thrombosis and Vascular Biology 2026
Citation only
Abstract Thu073: Senolytic drugs, dasatinib and quercetin, ameliorate age- and obesity-related metabolic and arterial dysfunction
Journal of Cachexia Sarcopenia and Muscle 2022
Open access · CC-BY
Reduction of senescent fibro‐adipogenic progenitors in progeria‐aged muscle by senolytics rescues the function of muscle stem cells
Integrative Journal of Orthopaedics and Traumatology 2021
Open access · OA
Senolytic Development in Osteoarthritis: A New Paradigm
Circulation 2022
Citation only